OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Serum lipoprotein (a) associates with the risk of renal function damage in the CHCN-BTH Study: Cross-sectional and Mendelian randomization analyses
Yunyi Xie, Han Qi, Bingxiao Li, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 7
Yunyi Xie, Han Qi, Bingxiao Li, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 7
Showing 7 citing articles:
Living with Elevated Lipoprotein(a) Levels: The Experiences of Patients and Caregivers
Elisabeth Steinhagen‐Thiessen, Magdalena Daccord, Emma C Print, et al.
Patient Preference and Adherence (2025) Vol. Volume 19, pp. 395-405
Open Access
Elisabeth Steinhagen‐Thiessen, Magdalena Daccord, Emma C Print, et al.
Patient Preference and Adherence (2025) Vol. Volume 19, pp. 395-405
Open Access
Tafolecimab in Chinese patients with non-familial hypercholesterolemia (CREDIT-1): a 48-week randomized, double-blind, placebo-controlled phase 3 trial
Yong Huo, Beijian Chen, Qiufang Lian, et al.
The Lancet Regional Health - Western Pacific (2023) Vol. 41, pp. 100907-100907
Open Access | Times Cited: 12
Yong Huo, Beijian Chen, Qiufang Lian, et al.
The Lancet Regional Health - Western Pacific (2023) Vol. 41, pp. 100907-100907
Open Access | Times Cited: 12
Lipoprotein(a) and the Risk for Recurrent Atherosclerotic Cardiovascular Events Among Adults With CKD: The Chronic Renal Insufficiency Cohort (CRIC) Study
Bharat Poudel, Robert S. Rosenson, Shia T. Kent, et al.
Kidney Medicine (2023) Vol. 5, Iss. 7, pp. 100648-100648
Open Access | Times Cited: 5
Bharat Poudel, Robert S. Rosenson, Shia T. Kent, et al.
Kidney Medicine (2023) Vol. 5, Iss. 7, pp. 100648-100648
Open Access | Times Cited: 5
High Lipoprotein(a) as a Cause of Kidney Disease
Sofie Bay Simony, Pia R. Kamstrup, Martin Bødtker Mortensen, et al.
Journal of the American College of Cardiology (2024)
Closed Access | Times Cited: 1
Sofie Bay Simony, Pia R. Kamstrup, Martin Bødtker Mortensen, et al.
Journal of the American College of Cardiology (2024)
Closed Access | Times Cited: 1
Association between lipoprotein(a) plasma levels and diabetic nephropathy in Han Chinese patients with type 2 diabetes mellitus
Ting Wang
PLoS ONE (2024) Vol. 19, Iss. 5, pp. e0299240-e0299240
Open Access
Ting Wang
PLoS ONE (2024) Vol. 19, Iss. 5, pp. e0299240-e0299240
Open Access
PCSK-9 inhibitors improve cardiovascular events after PCI in patients with chronic kidney disease
Hao Xu, Jian Li
Research Square (Research Square) (2024)
Closed Access
Hao Xu, Jian Li
Research Square (Research Square) (2024)
Closed Access
Lipoprotein (a) Cut-Off in Chronic Kidney Disease Patients with a History of Cardiovascular Disease in Center Hospital University Souro SANOU, Burkina Faso
Ollo Da, Aoua Semdé, Arnaud Kouraogo, et al.
Advances in Biological Chemistry (2023) Vol. 13, Iss. 06, pp. 228-235
Open Access
Ollo Da, Aoua Semdé, Arnaud Kouraogo, et al.
Advances in Biological Chemistry (2023) Vol. 13, Iss. 06, pp. 228-235
Open Access
